Dextromethorphan
Dextromethorphan is a pharmaceutical drug with 70 clinical trials. Currently 6 active trials ongoing. Historical success rate of 90.2%.
Success Metrics
Based on 46 completed trials
Phase Distribution
Phase Distribution
30
Early Stage
19
Mid Stage
16
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
86.8%
46 of 53 finished
13.2%
7 ended early
6
trials recruiting
70
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Dextromethorphan (CYP2D6 Substrate) in Healthy Participants
Psilocybin-facilitated Treatment for Chronic Pain
A Study of Imlunestrant (LY3484356) in Female Healthy Participants
Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan Dose Response Clinical Trial
Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan/Lidocaine Combination Clinical Trial
Clinical Trials (70)
A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Dextromethorphan (CYP2D6 Substrate) in Healthy Participants
Psilocybin-facilitated Treatment for Chronic Pain
A Study of Imlunestrant (LY3484356) in Female Healthy Participants
Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan Dose Response Clinical Trial
Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan/Lidocaine Combination Clinical Trial
A Study Investigating the Change in Metabolism Phenotype in Paediatric, Adolescent & Young Adults With Hodgkin or Non-Hodgkin Lymphoma.
Study of Dextromethorphan in OCD and Related Disorders
Pharmacological Mechanisms of Low-intensity Focused Ultrasound for Motor Cortex Neuroplasticity
Dextromethorphan as an Augmentation Agent in Treatment-resistant Schizophrenia
A Study Evaluating the Potential of BMS-984923 to Alter the Systemic Exposure of Three Orally Administered Probe Substrates
Effects of Isotretinoin on CYP2D6 Activity
Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors
PK Study to Assess Drug-drug Interaction and QTc Between Sitravatinib and a Cocktail of Substrates
Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects
Repurposing of Dextromethorphan as an Adjunct Therapy in Patients With Major Depressive Disorder
A Study of IBI351 in Healthy Subjects
DDI Study of Single Oral Dose of Acoziborole With Sequential Co-administration of Midazolam and Dextromethorphan
A Drug Interaction Study of LY3871801 in Healthy Participants
Dextromethorphan Added on for Children With Chronic Irritability
Three Dosing Regimens of Dextromethorphan (DXM) Reportedly Used in Major Depressive Disorder
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 70